Management of Tardive Dyskinesia in Elderly Patients

Assessment and Monitoring

Tardive dyskinesia is an involuntary movement disorder typically affecting the orofacial region but potentially involving any body part, associated with long-term use of dopamine receptor-blocking agents 1
Before initiating treatment, perform baseline assessment of abnormal movements using the Abnormal Involuntary Movement Scale (AIMS) to document severity 1
Regular monitoring should occur at least every 3-6 months using standardized measures like AIMS to track progression and treatment response 1, 2

If VMAT2 inhibitors are unavailable or ineffective, consider gradual withdrawal of the offending antipsychotic medication if clinically feasible 1
If VMAT2 inhibitors are unavailable or ineffective, consider switching to an atypical antipsychotic with lower TD risk if continued antipsychotic treatment is necessary 1

Use atypical antipsychotics when possible, as they have lower TD risk compared to typical antipsychotics 1
Provide adequate informed consent regarding TD risk when prescribing antipsychotics 1

When using clonazepam, start with very low doses due to increased sensitivity in the elderly and risk of falls 3

Continue regular monitoring even after symptom improvement to assess for potential worsening or recurrence 1